4.2 Editorial Material

Scarce Resources for Nuclear Detonation: Project Overview and Challenges

Journal

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1001/dmp.2011.15

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cardiac & Cardiovascular Systems

The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials

Stefan D. Anker, Stefan Agewall, Martin Borggrefe, Melanie Calvert, J. Jaime Caro, Martin R. Cowie, Ian Ford, Jean A. Paty, Jillian P. Riley, Karl Swedberg, Luigi Tavazzi, Ingela Wiklund, Paulus Kirchhof

EUROPEAN HEART JOURNAL (2014)

Article Economics

COMMUNICATING THE PARAMETER UNCERTAINTY IN THE IQWIG EFFICIENCY FRONTIER TO DECISION-MAKERS

Bjoern Stollenwerk, Stefan K. Lhachimi, Andrew Briggs, Elisabeth Fenwick, Jaime J. Caro, Uwe Siebert, Marion Danner, Andreas Gerber-Grote

HEALTH ECONOMICS (2015)

Letter Peripheral Vascular Disease

Reply to Vascular Endothelial Growth Factor: A Novel Potential Therapeutic Target for Hypertension

Morales Enrique, Caro Jara

JOURNAL OF CLINICAL HYPERTENSION (2013)

Article Chemistry, Multidisciplinary

Ethene/Ethane and Propene/Propane Separation via the Olefin and Paraffin Selective Metal-Organic Framework Adsorbents CPO-27 and ZIF-8

Ulrike Boehme, Benjamin Barth, Carolin Paula, Andreas Kuhnt, Wilhelm Schwieger, Alexander Mundstock, Juergen Caro, Martin Hartmann

LANGMUIR (2013)

Article Economics

Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States

Kit N. Simpson, Pamela P. Pei, Joergen Moeller, Robert W. Baran, Birgitta Dietz, William Woodward, Kristen Migliaccio-Walle, J. Jaime Caro

PHARMACOECONOMICS (2013)

Article Economics

Decision-Analytic Models: Current Methodological Challenges

J. Jaime Caro, Jorgen Moller

PHARMACOECONOMICS (2014)

Review Economics

Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature

Kevin Marsh, Tereza Lanitis, David Neasham, Panagiotis Orfanos, Jaime Caro

PHARMACOECONOMICS (2014)

Article Economics

Budget Impact Analysis Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

Sean D. Sullivan, Josephine A. Mauskopf, Federico Augustovski, J. Jaime Caro, Karen M. Lee, Mark Minchin, Ewa Orlewska, Pete Penna, Jose-Manuel Rodriguez Barrios, Wen-Yi Shau

VALUE IN HEALTH (2014)

Article Economics

Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report

J. Jaime Caro, David M. Eddy, Hong Kan, Cheryl Kaltz, Bimal Patel, Randa Eldessouki, Andrew H. Briggs

VALUE IN HEALTH (2014)

Article Endocrinology & Metabolism

Metabolic effects of regular physical exercise in healthy population

Juan Caro, Inmaculada Navarro, Pedro Romero, Rosario I. Lorente, Maria Antonia Priego, Sergio Martinez-Hervas, Jose T. Real, Juan F. Ascaso

ENDOCRINOLOGIA Y NUTRICION (2013)

Editorial Material Economics

Improving Transparency in Decision Models: Current Issues and Potential Solutions

Paul Tappenden, J. Jaime Caro

PHARMACOECONOMICS (2019)

Article Clinical Neurology

Prediction of Recurrent Ischemic Stroke Using Registry Data and Machine Learning Methods: The Erlangen Stroke Registry

Asmir Vodencarevic, Michael Weingaertner, J. Jaime Caro, Dubravka Ukalovic, Marcus Zimmermann-Rittereiser, Stefan Schwab, Peter Kolominsky-Rabas

Summary: This study developed accurate individual risk prediction models for recurrent ischemic stroke based on data easily obtained from patients at home. These models can be applied in a home setting to provide an initial risk assessment and identify high-risk patients early.

STROKE (2022)

Article Oncology

Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore

Brandon Chua, Li Min Lim, Joseph Soon Yau Ng, Yan Ma, Hwee Lin Wee, J. Jaime Caro

Summary: Extended genotyping (XGT) for cervical cancer screening, which identifies human papillomavirus (HPV) genotypes beyond HPV16 and HPV18, can provide risk stratification for clinical management. A study in Singapore compared the resource use, cost, and quality-adjusted life years (QALY) of XGT to partial genotyping (PGT). The results showed that XGT was cost-effective, utilized fewer resources, and provided a risk-based approach compared to PGT. This analysis, conducted in an Asian context, could guide the use of XGT in Asia.

CANCERS (2023)

No Data Available